Patient with pancreatic and esophageal cancer have a dismal prognosis and treatment response varies greatly between them. In the clinical work-up of pancreatic and esophageal cancer patients there is therefore a great demand for non-invasive makers that can stratify patients and predict treatment response. Potentially, such markers could be extracted using non-invasive, quantitative, imaging methods. Such quantitative imaging biomarkers can inform on biological processes involved in the development and treatment of cancer. The general aim of this thesis is to characterize the tumor microenvironment of pancreatic and esophagogastric cancer by quantitative imaging and to investigate if these methods enable to monitor treatment and predict pat...
ObjectivesFDG-PET provides quantitative information regarding the tumor glucosemetabolism which is u...
Cancer affects people worldwide, causing approximately 9.6 million deaths in 2018 globally. Although...
Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. ...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
Pancreatic adenocarcinoma is one of the deadliest human malignancies. Early detection is difficult a...
AbstractFunctional imaging gives information about physiological heterogeneity in tumours. The utili...
As anticancer therapies designed to target specific molecular pathways have been developed, it has b...
Objective: To discuss the correlation of contrast-enhanced CT quantitative parameters with prolifer...
Pancreatic cancer is the 10th most common malignancy and the 4th largest cancer killer in adults. Su...
'Radiomics' is the name given to the emerging field of extracting additional information from standa...
For patients diagnosed with stages IIa-IIb esophageal cancer, the current standard of care treatment...
none8siAim: To identify quantitative imaging biomarkers from multiparametric 18F-FDG-PET/MRI for pre...
The field of Radiomics aims to extract quantitative features from medical images. To date, hundreds ...
Pancreatic cancer, one of the most lethal malignancies, is increasing in incidence. While survival r...
Background: Aims of our research was to do the relative assessment of ultrasonography also CT Scan i...
ObjectivesFDG-PET provides quantitative information regarding the tumor glucosemetabolism which is u...
Cancer affects people worldwide, causing approximately 9.6 million deaths in 2018 globally. Although...
Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. ...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
Pancreatic adenocarcinoma is one of the deadliest human malignancies. Early detection is difficult a...
AbstractFunctional imaging gives information about physiological heterogeneity in tumours. The utili...
As anticancer therapies designed to target specific molecular pathways have been developed, it has b...
Objective: To discuss the correlation of contrast-enhanced CT quantitative parameters with prolifer...
Pancreatic cancer is the 10th most common malignancy and the 4th largest cancer killer in adults. Su...
'Radiomics' is the name given to the emerging field of extracting additional information from standa...
For patients diagnosed with stages IIa-IIb esophageal cancer, the current standard of care treatment...
none8siAim: To identify quantitative imaging biomarkers from multiparametric 18F-FDG-PET/MRI for pre...
The field of Radiomics aims to extract quantitative features from medical images. To date, hundreds ...
Pancreatic cancer, one of the most lethal malignancies, is increasing in incidence. While survival r...
Background: Aims of our research was to do the relative assessment of ultrasonography also CT Scan i...
ObjectivesFDG-PET provides quantitative information regarding the tumor glucosemetabolism which is u...
Cancer affects people worldwide, causing approximately 9.6 million deaths in 2018 globally. Although...
Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. ...